Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

Authors

John F. DiPersio, Washington University School of Medicine in St. Louis
et al

Journal

Journal of Hematology & Oncology

Publication Date

2017

Volume

10

Inclusive Pages

55

Document Type

Open Access Publication

DOI

10.1186/s13045-017-0417-z

Rights and Permissions

Verstovsek et al. Journal of Hematology & Oncology (2017) 10:55 DOI 10.1186/s13045-017-0417-z

Recommended Citation

DiPersio, John F. and et al, "Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial." Journal of Hematology & Oncology. 10, 55. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/6433